ADHD Adverse Drug Reaction Profiles Vary Across Medications in Children and Adolescents
Bioengineer.org
A multi-database study found significant variations in adverse drug reaction (ADR) profiles among ADHD medications in children and adolescents, with methylphenidate having the highest absolute number of reports but non-stimulants like guanfacine and atomoxetine showing higher incidence rates per person-year. The research highlights differences in ADR risk across medications, with school-aged children more frequently experiencing adverse reactions than adolescents, while no significant sex differences were observed. Common ADRs included appetite and gastrointestinal issues, while serious events like cardiovascular problems and seizures were also noted.
All articles from 17 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.
Get this news by email
Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.